BAUDAX BIO INC's ticker is BXRX and the CUSIP is 07160F107. A total of 49 filers reported holding BAUDAX BIO INC in Q2 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $0 | – | 1,627 | +1527.0% | 0.00% | – |
| Q3 2021 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 100 | -94.7% | 0.00% | – |
| Q4 2020 | $1,000 | -75.0% | 1,900 | +31.0% | 0.00% | – |
| Q3 2020 | $4,000 | -80.0% | 1,450 | -70.0% | 0.00% | – |
| Q2 2020 | $20,000 | -20.0% | 4,835 | -53.0% | 0.00% | – |
| Q1 2020 | $25,000 | – | 10,282 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 432,325 | $1,072,000 | 3.76% |
| NORTH RUN CAPITAL, LP | 1,152,539 | $2,858,000 | 2.87% |
| Stonepine Capital Management, LLC | 610,200 | $1,513,000 | 1.60% |
| Corsair Capital Management | 880,310 | $2,183,000 | 1.04% |
| SABBY MANAGEMENT, LLC | 373,977 | $927,000 | 0.38% |
| Engine Capital Management, LP | 78,787 | $545,000 | 0.28% |
| OBERWEIS ASSET MANAGEMENT INC/ | 91,620 | $227,000 | 0.12% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 98,385 | $244,000 | 0.05% |
| Alyeska Investment Group, L.P. | 815,384 | $2,022,000 | 0.04% |
| Ikarian Capital, LLC | 175,000 | $434,000 | 0.03% |